MUTATIONS IN ACCESSORY DNA REPLICATING FUNCTIONS ALTER THE RELATIVE MUTATION FREQUENCY OF HERPES-SIMPLEX VIRUS TYPE-1 STRAINS IN CULTURED MURINE CELLS
MUTATIONS IN ACCESSORY DNA REPLICATING FUNCTIONS ALTER THE RELATIVE MUTATION FREQUENCY OF HERPES-SIMPLEX VIRUS TYPE-1 STRAINS IN CULTURED MURINE CELLS
复制标题
DOI:
10.1128/jvi.68.7.4514-4524.1994
复制
发表时间:
1994-07-01
影响因子:
5.4
通讯作者:
THOMPSON, RL
中科院分区:
文献类型:
--
作者:
PYLES, RB;THOMPSON, RL
The contribution of the herpes simplex virus type 1 (HSV-1)-encoded uracil DNA glycosylase (UNG), thymidine kinase (TK), and dUTPase to the relative mutant frequency (RMF) of the virus in cultured murine cells was examined. A panel of HSV-1 mutants that lacked singly or doubly the UNG, TK, or dUTPase activity were generated by disruption of the enzyme coding regions with the Escherichia coli beta-galactosidase (beta-gal) gene in strain 17syn(+). To establish a baseline RMF of strain 17syn(+), the beta-gal gene was inserted into the UL3 locus. In all of the viruses, the beta-gal insert served as a phenotypic marker of RMP. A mutant plaque,vas identified by the lack of beta-gal activity and, in selected cases, positive in situ hybridization for beta-gal sequences. Replication kinetics in NIH 3T3 cells demonstrated that all of the mutants replicated efficiently, generating stocks with equivalent titers. Two independently generated UL3-beta-gal viruses were examined and established a baseline RMF of similar to 0.5% in both NIH 3T3 and LM TK- cells. Loss of dUTPase activity resulted in viruses with fivefold-increased RMFs, indicating that the HSV-1 dUTPase has an antimutator function. The RMF observed for the tk(-) viruses was reduced as much as 40-fold (RMF of 0.02%), suggesting that the viral TK is a mutator activity. The RMF of tito independent UNG(-) viruses showed no significant difference from the baseline RMF in limited passage; however, following successive passage, the data suggested that UNG activity serves as an antimutator. These results have implications for the natural history of HSV and the development of antiviral therapies.